![](https://investorshub.advfn.com/uicon/622384.png?cb=1514056441)
Friday, September 20, 2019 6:47:34 AM
GO PRED! In it to win it.
PRED Shares Are Valuable. To support valuation, in part, consider:
Dr. Taylor's published research papers and data to be presented at ASRM, and the launch of PRED's ARTguide genetic diagnostics for endometriosis and the 24 million U.S. women who are symptomatic (and 14 million diagnosed) with endometriosis;
PRED's Mike Day who was the key executive that built Wyeth Women's Health, e.g., Wyeth was sold to Pfizer in 2009 for $68 billion;
John Sorrentino, PRED's Chairman who was until early this year COO and SVP at Pfizer responsible for $34+ billion in annual revenue;
And other seasoned individuals within PRED of equal track records in life science and public companies.
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM